Transaction DateRecipientSharesTypePriceValue
30th September 2020Management, Llc Newtyn3,850,000Disposition due to a tender of shares in a change of control transaction$0.00
30th September 2020Asset Management Lp Weiss801,424Disposition due to a tender of shares in a change of control transaction$12.00$9,617,088.00
29th September 2020Asset Management Lp Weiss100,000Open or private sale$12.74$1,273,580.00
16th June 2020Patrick K. Lucy770Exercise of derivative$3.38$2,602.60
16th June 2020Patrick K. Lucy770Open or private sale$10.23$7,873.33
2nd March 2020Patrick K. Lucy17,151Open or private sale$11.24$192,706.92
2nd March 2020Patrick K. Lucy17,151Exercise of derivative$3.38$57,970.38
27th November 2019Patrick K. Lucy3,000Open or private sale$10.03$30,104.40
16th September 2019Patrick K. Lucy250Open or private sale$10.01$2,502.50
16th September 2019Patrick K. Lucy1,800Open or private sale$10.00$18,000.00
Pfenex
Pfenex logo

Pfênex, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.


Ticker: PFNX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1478121
Employees: 81
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals